Solventum Corp (SOLV) Q4 2024 Earnings Call

Concluded Feb 27, 2025

Feb 27, 2025 0 turns

Period: FY2024 Q4
Runtime: —
Sources: 2 artifacts

8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Portfolio optimization and M&A 28 Separation from 3M and ERP cutover 19 Q1 results beat and momentum 18 Health Information Systems / RCM and AI 13 Transform for the Future / cost savings program 13 MedSurg segment performance 11

Management tone

Confident

Net tone +62 · low hedging

Grounding quotes

“We delivered first quarter results ahead of our plan and ahead of expectations. Organic sales growth and EPS both exceeded our plan, and it's, again, reflecting a very strong execution across the organization and the momentum that we've already built.”
“Q1 is a clear indication that we are well on our way to delivering our 2026 guidance and, importantly, our go-forward LRP objectives.”
“We do see momentum in the business. We do see our growth rate strengthening. Q1 was a very tough comp, so we would expect our growth rate to improve. And we'd also expect our earnings per share to improve because our operating margin is also improving.”
“this team has tripled the comparable sales growth from our starting point”

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Revenue · derived Q4 $2.08B +1.9% YoY

Gross margin · derived Q4 53.9% -3.0 pp YoY

Net income · derived Q4 $31.00M -88.6% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Feb 27, 2025 10-K report Filed Feb 28, 2025

Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →